Jubilant Biosys signs partnership with Pierre Fabre SA

hanuman

Active member
Partnership.jpg


Jubilant Biosys Innovative Research Services (JBIRSPL), Singapore, subsidiary of Jubilant Biosys, a wholly owned subsidiary of Jubilant Pharmova and Pierre Fabre SA are entering in a strategic partnership. Pursuant to this, JBIRSPL would acquire 80 per cent equity capital in Jasmin (new company incorporated in France, as a Société par Actions Simplifiée (SAS), 100 per cent owned by Pierre Fabre). Jasmin shall acquire Pierre Fabre’s R&D Centre (including R&D Site and R&D activities) at Saint Julien, France upon closing of the transaction.

This strategic partnership will enable Jubilant Biosys to expand its footprint in Europe in areas like Biologics (mAbs) and Antibody Drug Conjugate (ADC), in addition to its existing services including integrated drug discovery services from India.

The post appeared first on .
 
Top
AdBlock Detected

We get it, advertisements are annoying!

Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.

I've Disabled AdBlock